Skip to content

Scott Henry Maurer, MD

NPI 1104935840ActiveIndividual· Pediatrics, Pediatric Hematology-Oncology· Pittsburgh, PA

Pediatrics, Pediatric Hematology-Oncology (MD) in Pittsburgh, Pennsylvania, licensed in PA, with an NPI issued in August 2006. Part D covered 31 prescriptions written in 2024, 97% of them generic. Novo Nordisk Inc reported $69.03 in payments in 2025, mostly food and beverage.

Overview

NPI1104935840
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 29, 2006
Last updated in NPPESJun 17, 2011

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Hematology-Oncology Primary2080P0207XMD439647PA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Pediatric Medicine (PA)

Part D prescriptions in 2024

Prescriptions (claims)31 · 31 30-day fills
Total drug cost$720.78
Generic share97% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$69.03 · 3 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$69.033

What the 2025 payments were for

  • Food and Beverage$69.03 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Hematology-Oncology providers in Pittsburgh

All 23 Pediatrics, Pediatric Hematology-Oncology providers in Pittsburgh · All Pediatrics, Pediatric Hematology-Oncology providers in Pennsylvania